Long-term follow up of the CLL2007FMP trial evaluating fludarabine and cyclophosphamide in combination with either rituximab or alemtuzumab in previously untreated patients with chronic lymphocytic leukemia.
Saved in:
| Title: | Long-term follow up of the CLL2007FMP trial evaluating fludarabine and cyclophosphamide in combination with either rituximab or alemtuzumab in previously untreated patients with chronic lymphocytic leukemia. |
|---|---|
| Authors: | Feugier P; Service d'Hématologie, Centre Hospitalier Universitaire and INSERM 1256, Faculté de Médecine, Université de Lorraine, Vandoeuvrelès-Nancy, France p.feugier@chru-nancy.fr., Aurran T; Service d'Hématologie, Institut Paoli-Calmettes, Marseille, France., Mahé B; Service d'Hématologie, Centre Hospitalier Universitaire, Nantes, France., Letestu R; Service Hématologie biologique, Hôpital Avicenne, AP-HP, UMR INSERM U978 Université Paris 13, Bobigny, France., Nguyen-Khac F; Unité Fonctionnelle de Cytogénétique Hématologique, Groupe Hospitalier Pitié-Salpêtrière, UPMC Paris 6, INSERM U1138, Paris, France., Cazin B; Service d'Hématologie, Centre Hospitalier Universitaire, Lille, France., Tournilhac O; Service d'Hématologie, Centre Hospitalier Universitaire, Clermont-Ferrand, France., Maisonneuve H; Service d'Onco-Hématologie, Centre Hospitalier, La Roche Sur Yon, France., Casasnovas O; Service d'Hématologie, Centre Hospitalier Universitaire, Dijon, France., Delmer A; Service d'Hématologie, Centre Hospitalier Universitaire, Reims, and Université Reims Champagne Ardenne (URCA), France., Leblond V; Service d'Hématologie, Hôpital de la Pitié-Salpêtrière, Paris, France., Royer B; Service d'Hématologie, Centre Hospitalier Universitaire, Amiens, France., Corront B; Service d'Hématologie, Centre Hospitalier, Annecy, France., Chevret S; Centre d'Investigation Clinique, Hôpital Saint Louis, Paris, France., Delépine R; Service d'Hématologie et Thérapie Cellulaire, Centre Hospitalier Universitaire, Tours, France., Vaudaux S; INSERM U1245 and Department of Hematology, Centre Henri Becquerel and Normandie University UNIROUEN, Rouen, France., Van Den Neste E; Service d'Hématologie, Cliniques Universitaires UCL Saint Luc, Bruxelles, Belgique., Béné MC; Service d'Hématologie, Centre Hospitalier Universitaire, Nantes, France., Cymbalista F; Service Hématologie biologique, Hôpital Avicenne, AP-HP, UMR INSERM U978 Université Paris 13, Bobigny, France., Ross-Weil D; Service d'Hématologie, Hôpital de la Pitié-Salpêtrière, Paris, France., Leprêtre S; INSERM U1245 and Department of Hematology, Centre Henri Becquerel and Normandie University UNIROUEN, Rouen, France. |
| Source: | Haematologica [Haematologica] 2018 Jul; Vol. 103 (7), pp. e304-e306. Date of Electronic Publication: 2018 Mar 15. |
| Publication Type: | Letter; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Ferrata Storti Foundation Country of Publication: Italy NLM ID: 0417435 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1592-8721 (Electronic) Linking ISSN: 03906078 NLM ISO Abbreviation: Haematologica |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 29545348 AccessLevel: 2 PubType: Report PubTypeId: report PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Long-term follow up of the CLL2007FMP trial evaluating fludarabine and cyclophosphamide in combination with either rituximab or alemtuzumab in previously untreated patients with chronic lymphocytic leukemia. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Feugier+P%22">Feugier P</searchLink>; Service d'Hématologie, Centre Hospitalier Universitaire and INSERM 1256, Faculté de Médecine, Université de Lorraine, Vandoeuvrelès-Nancy, France p.feugier@chru-nancy.fr.<br /><searchLink fieldCode="AU" term="%22Aurran+T%22">Aurran T</searchLink>; Service d'Hématologie, Institut Paoli-Calmettes, Marseille, France.<br /><searchLink fieldCode="AU" term="%22Mahé+B%22">Mahé B</searchLink>; Service d'Hématologie, Centre Hospitalier Universitaire, Nantes, France.<br /><searchLink fieldCode="AU" term="%22Letestu+R%22">Letestu R</searchLink>; Service Hématologie biologique, Hôpital Avicenne, AP-HP, UMR INSERM U978 Université Paris 13, Bobigny, France.<br /><searchLink fieldCode="AU" term="%22Nguyen-Khac+F%22">Nguyen-Khac F</searchLink>; Unité Fonctionnelle de Cytogénétique Hématologique, Groupe Hospitalier Pitié-Salpêtrière, UPMC Paris 6, INSERM U1138, Paris, France.<br /><searchLink fieldCode="AU" term="%22Cazin+B%22">Cazin B</searchLink>; Service d'Hématologie, Centre Hospitalier Universitaire, Lille, France.<br /><searchLink fieldCode="AU" term="%22Tournilhac+O%22">Tournilhac O</searchLink>; Service d'Hématologie, Centre Hospitalier Universitaire, Clermont-Ferrand, France.<br /><searchLink fieldCode="AU" term="%22Maisonneuve+H%22">Maisonneuve H</searchLink>; Service d'Onco-Hématologie, Centre Hospitalier, La Roche Sur Yon, France.<br /><searchLink fieldCode="AU" term="%22Casasnovas+O%22">Casasnovas O</searchLink>; Service d'Hématologie, Centre Hospitalier Universitaire, Dijon, France.<br /><searchLink fieldCode="AU" term="%22Delmer+A%22">Delmer A</searchLink>; Service d'Hématologie, Centre Hospitalier Universitaire, Reims, and Université Reims Champagne Ardenne (URCA), France.<br /><searchLink fieldCode="AU" term="%22Leblond+V%22">Leblond V</searchLink>; Service d'Hématologie, Hôpital de la Pitié-Salpêtrière, Paris, France.<br /><searchLink fieldCode="AU" term="%22Royer+B%22">Royer B</searchLink>; Service d'Hématologie, Centre Hospitalier Universitaire, Amiens, France.<br /><searchLink fieldCode="AU" term="%22Corront+B%22">Corront B</searchLink>; Service d'Hématologie, Centre Hospitalier, Annecy, France.<br /><searchLink fieldCode="AU" term="%22Chevret+S%22">Chevret S</searchLink>; Centre d'Investigation Clinique, Hôpital Saint Louis, Paris, France.<br /><searchLink fieldCode="AU" term="%22Delépine+R%22">Delépine R</searchLink>; Service d'Hématologie et Thérapie Cellulaire, Centre Hospitalier Universitaire, Tours, France.<br /><searchLink fieldCode="AU" term="%22Vaudaux+S%22">Vaudaux S</searchLink>; INSERM U1245 and Department of Hematology, Centre Henri Becquerel and Normandie University UNIROUEN, Rouen, France.<br /><searchLink fieldCode="AU" term="%22Van+Den+Neste+E%22">Van Den Neste E</searchLink>; Service d'Hématologie, Cliniques Universitaires UCL Saint Luc, Bruxelles, Belgique.<br /><searchLink fieldCode="AU" term="%22Béné+MC%22">Béné MC</searchLink>; Service d'Hématologie, Centre Hospitalier Universitaire, Nantes, France.<br /><searchLink fieldCode="AU" term="%22Cymbalista+F%22">Cymbalista F</searchLink>; Service Hématologie biologique, Hôpital Avicenne, AP-HP, UMR INSERM U978 Université Paris 13, Bobigny, France.<br /><searchLink fieldCode="AU" term="%22Ross-Weil+D%22">Ross-Weil D</searchLink>; Service d'Hématologie, Hôpital de la Pitié-Salpêtrière, Paris, France.<br /><searchLink fieldCode="AU" term="%22Leprêtre+S%22">Leprêtre S</searchLink>; INSERM U1245 and Department of Hematology, Centre Henri Becquerel and Normandie University UNIROUEN, Rouen, France. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%220417435%22">Haematologica</searchLink> [Haematologica] 2018 Jul; Vol. 103 (7), pp. e304-e306. <i>Date of Electronic Publication: </i>2018 Mar 15. – Name: TypePub Label: Publication Type Group: TypPub Data: Letter; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Ferrata+Storti+Foundation%22">Ferrata Storti Foundation </searchLink><i>Country of Publication: </i>Italy <i>NLM ID: </i>0417435 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1592-8721 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2203906078%22">03906078 </searchLink><i>NLM ISO Abbreviation: </i>Haematologica |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=29545348 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.3324/haematol.2017.183350 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: e304 Titles: – TitleFull: Long-term follow up of the CLL2007FMP trial evaluating fludarabine and cyclophosphamide in combination with either rituximab or alemtuzumab in previously untreated patients with chronic lymphocytic leukemia. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Feugier P – PersonEntity: Name: NameFull: Aurran T – PersonEntity: Name: NameFull: Mahé B – PersonEntity: Name: NameFull: Letestu R – PersonEntity: Name: NameFull: Nguyen-Khac F – PersonEntity: Name: NameFull: Cazin B – PersonEntity: Name: NameFull: Tournilhac O – PersonEntity: Name: NameFull: Maisonneuve H – PersonEntity: Name: NameFull: Casasnovas O – PersonEntity: Name: NameFull: Delmer A – PersonEntity: Name: NameFull: Leblond V – PersonEntity: Name: NameFull: Royer B – PersonEntity: Name: NameFull: Corront B – PersonEntity: Name: NameFull: Chevret S – PersonEntity: Name: NameFull: Delépine R – PersonEntity: Name: NameFull: Vaudaux S – PersonEntity: Name: NameFull: Van Den Neste E – PersonEntity: Name: NameFull: Béné MC – PersonEntity: Name: NameFull: Cymbalista F – PersonEntity: Name: NameFull: Ross-Weil D – PersonEntity: Name: NameFull: Leprêtre S IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 07 Text: 2018 Jul Type: published Y: 2018 Identifiers: – Type: issn-electronic Value: 1592-8721 Numbering: – Type: volume Value: 103 – Type: issue Value: 7 Titles: – TitleFull: Haematologica Type: main |
| ResultId | 1 |
